Swiftmerge Acquisition Operating Expenses 1970-1969 | ANNA

Swiftmerge Acquisition operating expenses from 1970 to 1969. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Swiftmerge Acquisition Annual Operating Expenses
(Millions of US $)
Swiftmerge Acquisition Quarterly Operating Expenses
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.042B $0.000B
Swiftmerge Acquisition Corp. entered into definitive merger agreement with HDL Therapeutics Inc.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00